Intuitive Surgical stock: Baird raises target for Intuitive Surgical stock to USD 513.00

Published on 10/20/2026 at 15:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue rose 19.00 percent in the second quarter. Intuitive Surgical stock costs EUR 386.73 on October 20, 2026, up 1.46 percent versus Xetra close.

Target, earnings and trading

Baird raised its Intuitive Surgical target to USD 513.00 from USD 500.00 on October 15, 2026.
Second-quarter revenue rose 19.00 percent to USD 2.89 billion.
Intuitive Surgical stock costs EUR 386.73 at Lang & Schwarz on October 20, 2026 at 3:33 p.m. CEST, 1.46 percent above the Xetra close of October 16, 2026.

Schwarzweiß-Reportagefoto eines Chirurgen an der Konsole während einer robotergestützten Operation — Dokumentarische Schwarzweiß-Reportage aus dem OP-Saal illustriert Intuitive Surgical Inc. (US46120E6023) und den Arbeitsalltag der Chirurgie-Robotik, Illustration mit AI erstellt.

Intuitive Surgical stock (ISIN US46120E6023) is trading at EUR 386.73 at Lang & Schwarz on October 20, 2026 at 3:33 p.m. CEST, up 1.46 percent versus the Xetra close of October 16, 2026 at EUR 381.15. Baird raised its price target from USD 500.00 to USD 513.00 on October 15, 2026, according to Yahoo Finance.

Revenue grew in the second quarter

Intuitive Surgical reported second-quarter revenue of USD 2.89 billion, a 19.00 percent increase from the year-earlier period. GAAP net income reached USD 818.00 million, compared with USD 658.00 million a year earlier, while diluted earnings per share rose to USD 2.29 from USD 1.81, according to Fortune.

Stock remains below its yearly high

The Nasdaq quote was USD 433.63 at 9:41 a.m. EDT on October 20, 2026. The 52-week range was USD 328.57 to USD 603.88, placing the share 28.19 percent below its high. The market capitalization was USD 153.2 billion and the price-to-earnings ratio was 49.31 on the same date.

Target implies 18.30 percent upside

Baird's USD 513.00 target lies 18.30 percent above the Nasdaq price of USD 433.63, using the October 20, 2026 quotation. The company listed its third-quarter earnings conference call for October 20, 2026 at 1:30 p.m. PDT on its investor calendar, Intuitive Surgical.

Trading stays tied to valuation

The current Nasdaq valuation gives the target debate particular weight because the stock trades at 49.31 times earnings. At the same time, second-quarter revenue growth of 19.00 percent and net income growth of 24.32 percent provide the operating figures behind the valuation discussion.

Price and investor perspective

Intuitive Surgical was trading at EUR 386.73 at Lang & Schwarz on October 20, 2026 at 3:33 p.m. CEST, 1.46 percent above the Xetra close of October 16, 2026 at EUR 381.15. The Nasdaq quotation was USD 433.63 at 9:41 a.m. EDT on October 20, 2026. The further course of trading is shown by the continuously updated real-time quote of Intuitive Surgical stock.